|
|
Volumn 29, Issue 5, 1999, Pages 1581-1586
|
|
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HEADACHE;
HEPATITIS B;
HUMAN;
LIVER BIOPSY;
LIVER HISTOLOGY;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REMISSION;
TREATMENT OUTCOME;
VIRUS DETECTION;
VIRUS LOAD;
VOMITING;
ADULT;
AGED;
ANTIVIRAL AGENTS;
DNA, VIRAL;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
LAMIVUDINE;
LIVER;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
|
|
EID: 0032899269
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510290507 Document Type: Article |
|
Times cited : (274)
|
|
References (2)
|
